Memantine in moderate-to-severe Alzheimer disease evidence and ethics based?

Alzheimer Dis Assoc Disord. 2004 Jan-Mar;18(1):47-8; author reply 48. doi: 10.1097/00002093-200401000-00010.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Clinical Trials as Topic
  • Endpoint Determination
  • Evidence-Based Medicine
  • Excitatory Amino Acid Antagonists / therapeutic use*
  • Humans
  • Medical Futility
  • Memantine / therapeutic use*
  • Patient Selection*
  • Severity of Illness Index

Substances

  • Excitatory Amino Acid Antagonists
  • Memantine